|
1
|
Suicide and cardiovascular death after a cancer diagnosis.
|
N Engl J Med
|
2012
|
3.56
|
|
2
|
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
|
J Natl Cancer Inst
|
2008
|
3.55
|
|
3
|
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
|
Cancer Cell
|
2008
|
2.87
|
|
4
|
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.
|
J Natl Cancer Inst
|
2009
|
2.50
|
|
5
|
Molecular sampling of prostate cancer: a dilemma for predicting disease progression.
|
BMC Med Genomics
|
2010
|
2.40
|
|
6
|
How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden.
|
J Urol
|
2006
|
2.21
|
|
7
|
Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.
|
J Natl Cancer Inst
|
2010
|
2.18
|
|
8
|
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
|
Eur Urol
|
2009
|
1.49
|
|
9
|
Consumption of fish products across the lifespan and prostate cancer risk.
|
PLoS One
|
2013
|
1.46
|
|
10
|
Amyotrophic lateral sclerosis in Sweden, 1991-2005.
|
Arch Neurol
|
2009
|
1.44
|
|
11
|
mRNA expression signature of Gleason grade predicts lethal prostate cancer.
|
J Clin Oncol
|
2011
|
1.40
|
|
12
|
Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.35
|
|
13
|
Macrolide resistance in the normal microbiota after Helicobacter pylori treatment.
|
Scand J Infect Dis
|
2007
|
1.27
|
|
14
|
Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.26
|
|
15
|
Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
|
PLoS One
|
2011
|
1.25
|
|
16
|
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.13
|
|
17
|
Genetic variation in RNASEL associated with prostate cancer risk and progression.
|
Carcinogenesis
|
2010
|
1.12
|
|
18
|
Sleep disruption among older men and risk of prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.10
|
|
19
|
Risk of bilateral renal cell cancer.
|
J Clin Oncol
|
2009
|
1.04
|
|
20
|
Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden.
|
Clin Cancer Res
|
2012
|
1.03
|
|
21
|
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry.
|
J Clin Pathol
|
2012
|
1.03
|
|
22
|
Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.03
|
|
23
|
Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden.
|
Am J Epidemiol
|
2012
|
1.01
|
|
24
|
Risk of infection-related cancers after the loss of a child: a follow-up study in Sweden.
|
Cancer Res
|
2010
|
0.99
|
|
25
|
Dietary zinc and prostate cancer survival in a Swedish cohort.
|
Am J Clin Nutr
|
2011
|
0.94
|
|
26
|
Suicide among patients with amyotrophic lateral sclerosis.
|
Brain
|
2008
|
0.92
|
|
27
|
One-carbon metabolism-related nutrients and prostate cancer survival.
|
Am J Clin Nutr
|
2009
|
0.91
|
|
28
|
Risk of suicide in men with low-risk prostate cancer.
|
Eur J Cancer
|
2013
|
0.89
|
|
29
|
An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-twin study.
|
Am J Epidemiol
|
2009
|
0.88
|
|
30
|
Milk intake in early life and risk of advanced prostate cancer.
|
Am J Epidemiol
|
2011
|
0.88
|
|
31
|
Rye bread consumption in early life and reduced risk of advanced prostate cancer.
|
Cancer Causes Control
|
2012
|
0.86
|
|
32
|
Immunohistochemical expression of BRCA1 and lethal prostate cancer.
|
Cancer Res
|
2010
|
0.86
|
|
33
|
Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
|
Prostate
|
2011
|
0.85
|
|
34
|
Loss of a parent and the risk of cancer in early life: a nationwide cohort study.
|
Cancer Causes Control
|
2014
|
0.85
|
|
35
|
CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer.
|
Mod Pathol
|
2012
|
0.84
|
|
36
|
Pancreatic cancer risk after loss of a child: a register-based study in Sweden during 1991-2009.
|
Am J Epidemiol
|
2013
|
0.83
|
|
37
|
Loss of a child and the risk of amyotrophic lateral sclerosis.
|
Am J Epidemiol
|
2007
|
0.80
|
|
38
|
Spousal loss and cognitive function in later life: a 25-year follow-up in the AGES-Reykjavik study.
|
Am J Epidemiol
|
2014
|
0.78
|
|
39
|
Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.
|
Cancer Causes Control
|
2012
|
0.77
|
|
40
|
Hospitalization for osteoarthritis and prostate cancer specific mortality among Swedish men with prostate cancer.
|
Cancer Epidemiol
|
2010
|
0.77
|
|
41
|
Mortality following a brain tumour diagnosis in patients with multiple sclerosis.
|
BMJ Open
|
2013
|
0.76
|
|
42
|
Genetic variation across C-reactive protein and risk of prostate cancer.
|
Prostate
|
2014
|
0.75
|
|
43
|
Stress and cancer: Nordic pieces to the complex puzzle.
|
Eur J Epidemiol
|
2015
|
0.75
|
|
44
|
Analysis of incidence and prognosis from 'extreme' case-control designs.
|
Stat Med
|
2014
|
0.75
|